RSI low/high Values: [ 20 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Lucira Health, Inc. Stock and on which exchange is it traded?
The symbol for Lucira Health, Inc. is LHDX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Lucira Health, Inc. Stock?
Lucira Health, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Lucira Health, Inc. Stock?
Lucira Health, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Lucira Health, Inc. Stock.

What's the current price of Lucira Health, Inc. Stock?
As of the end of day on the May 30, 2023, the price of an Lucira Health, Inc. (LHDX) share was $0.452.

What is the 52-week high and low for Lucira Health, Inc. Stock?
The 52-week high for Lucira Health, Inc. Stock is $3.58 and the 52-week low is $0.108.

What is the market capitalization of Lucira Health, Inc. Stock?
As of the May 30, 2023, the market capitalization of Lucira Health, Inc. is 18.363M.
Click to get the best stock tips daily for free!

About Lucira Health, Inc.

Lucira Health. Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical Co., Ltd.; technical services agreement with Jabil, Inc.; and m... LHDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT